Debjani Pal

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Nature genetics

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B Barry Toure, Songping Zhao, Roberto Valverde, Patrick J O'Hearn, Demetri T Moustakas, Heike Schonherr, Nastaran Gerami-Moayed, Alexander M Taylor, Brandi M Hudson, Damian J Houde, Debjani Pal, Lindsey Foster, Hakan Gunaydin, Pelin Ayaz, Dina A Sharon, Lipika Goyal, Alison M Schram, Suneel D Kamath, Cori Ann Sherwin, Oleg Schmidt-Kittler, Kai Yu Jen, Fabien Ricard, Beni B Wolf, David E Shaw, Donald A Bergstrom, James Watters, Jessica B Casaletto
RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations. Cancer discovery (2023)
Takahiro Ito, Michael J Young, Ruitong Li, Sidharth S Jain, Andreas Wernitznig, John Michael Krill-Burger, Christopher T Lemke, Davide Monducci, Diego J Rodriguez, Liang Chang, Sanjukta Dutta, Debjani Pal, Brenton R Paolella, Michael V Rothberg, David E Root, Cory M Johannessen, Laxmi Parida, Gad A Getz, Francisca Vazquez, John G Doench, Mahdi Zamanighomi, William R Sellers
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nature genetics 53 (12) (2021)